Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
This study isn't currently recruiting.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In FinlandThis study isn't currently recruiting.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In Ireland
This study isn't currently recruiting.
In United KingdomThis study isn't currently recruiting.
In United Kingdom
This study isn't currently recruiting.
In Italy12 Week Open Label, Multicenter, Non-Comparative Switch Study Evaluating Efficacy, Tolerability And Safety Of Oral Ziprasidone In Treatment Of Patients Suffering From Schizophrenia Who Have Already Been Treated With An Other Antipsychotic.
This study ended early.
Multiple locations, including BudapestA Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
This study has finished and is no longer accepting participants.
Multiple locations, including Bullhead City"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms"
This study ended early.
Multiple locations, including AnaheimA Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms
This study ended early.
Multiple locations, including Little RockR076477-SCH-702: a 24 Week Open-Label Extension to R076477-SCH-302
This study has finished and is no longer accepting participants.
Location not clearly listedA Prospective, Randomized, Active-controlled, Rater-blinded Study of the Prevention of Relapse Comparing Paliperidone Palmitate With Oral Risperidone in Adults With Recently-Diagnosed Schizophrenia Who Are at High Risk of Relapse
This study ended early.
Multiple locations, including Little RockEffects of 5-HTR2A, DRD2,and COMT Genes Polymorphisms and Drug Plasma Concentration on Antipsychotic Response to Olanzapine in Treatment of Early-onset Schizophrenia
This study has finished and is no longer accepting participants.
In KunmingWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.